A nomogram based on combining clinical features and contrast enhanced ultrasound is not able to identify Her-2 over-expressing cancer from other breast cancers

Overview of attention for article published in Frontiers in oncology, January 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 24,399 followers.

We've detected a paper from Frontiers in Oncology that cites a retracted paper post-retraction. Citing paper: https://t.co/FV4mjygpWv Retracted paper: https://t.co/AXuc6RgYRC

21 Mar 2023

Reply Repost Favourite

A nomogram based on combining clinical features and contrast enhanced ultrasound is not able to identify Her-2 over-expressing cancer from other breast cancers https://t.co/8i2eky6n4d https://t.co/gHX0dhWoqd

26 Jan 2023

Reply Repost Favourite

New research: A nomogram based on combining clinical features and contrast enhanced ultrasound is not able to identify Her-2 over-expressing cancer from other breast cancers: Objective The aim of this study was to evaluate whether a predictive… https://t.

26 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.